Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapyPriyamvada Jayaprakash, Michael A. Curran|Journal of Clinical Investigation|2018Cited by 390
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trialMatthew J. Reilley, David S. Hong, Carl Cook et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 286
Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid LeukemiaAkash R. Boda, Michael A. Curran|Cancer Research Communications|2024Cited by 4